|
|
¹ÙÀÌ¿À¸¶Ä¿ÀÇ ±â¼ú, ½ÃÀå, ±â¾÷ Biomarkers - technologies,markets and companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| ´Ù¾çÇÑ Á¾·ùÀÇ ¹ÙÀÌ¿À¸¶Ä¿ °³¿ä, ¹ÙÀÌ¿À¸¶Ä¿ ¹ßÀüÀ» À§ÇÑ °¢Á¾ ±â¼ú, °¢Á¾ Áúº´ ºÐ¾ß¿¡¼ ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ¿ªÇÒ µîÀ» Á¶»ç ºÐ¼®ÇÏ°í ±ÔÁ¦»óÀÇ °úÁ¦, ¹ÌÃÑÁ· ¿ä°Ç, ½ÃÀ强Àå ¿¹Ãø µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. |
|
¼¼Æ÷À¯ÀüÇÐ(Cytogenetics) : ±â¼ú¡¤½ÃÀ塤±â¾÷ Cytogenetics - technologies,markets and companies |
|
Pub Time : 2010/02 Published by : Jain Pharmabiotech |
| ¿°»öü ±¸Á¶ÀÇ ¼ö½Ä ¹× Áúȯ¿¡ °ü·ÃµÈ ÀÌ»óÀ» ƯÁ¤ÇÏ´Â ¼¼Æ÷À¯ÀüÇÐ(Cytogenetics)¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. |
|
Áß±¹ÀÇ Ã¼¿ÜÁø´Ü ½ÃÀå Chinese Markets for In Vitro Diagnostics |
|
Pub Time : 2010/01 Published by : Asia Market Information & Development Co. |
| Áß±¹ÀÇ °æÁ¦ µ¿Çâ, ü¿ÜÁø´Ü ½ÃÀåÀÇ ÅõÀÚ È¯°æ, »ê¾÷ÀÇ ¹ßÀü, ¼ö¿ä ¹× °ø±Þ, »ê¾÷ ±¸Á¶, ½ÃÀå ä³Î ¹× ÁÖ¿ä ±â¾÷ µî¿¡ ´ëÇØ »ó¼¼È÷ Á¶»çÇϰí, 2003³â ¹× 2008³âÀÇ ½ÇÀû, 2013³â ¹× 2018³âÀÇ Àå±â ¿¹ÃøÀ» ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ Point of Care(POC) ½ÃÀå Point of Care Diagnostics |
|
Pub Time : 2009/12 Published by : BCC Research |
| ¼¼°è Point of Care(POC) ½ÃÀåÀÇ ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, °Ë»ç À¯Çü¡¤Áö¿ªº° ½ÃÀå ¼ºÀå ¿¹Ãø(¡2014³â), ÁÖ¿ä Á¦Á¶¾÷ÀÚÀÇ ½ÃÀå Á¡À¯À², °¢Á¾ ½ÃÀå ¿µÇâ¿äÀÎ, Ãâ½Ã Á¦Ç°ÀÇ °³¿ä, ÀÌ¿ë ±â¼ú, ÁÖ¿ä Âü°¡±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¹Ì±¹ÀÇ µ¿¹Ý Áø´Ü ½ÃÀå U.S. Companion Diagnostics Markets |
|
Pub Time : 2009/12 Published by : Frost & Sullivan |
| ¹Ì±¹ÀÇ µ¿¹Ý Áø´Ü ½ÃÀå¿¡ ´ëÇØ »ó¼¼È÷ ºÐ¼®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
ÀεµÀÇ Ã¼¿Ü Áø´Ü ½ÃÀå Indian In-vitro Diagnostics Market |
|
Pub Time : 2009/12 Published by : Frost & Sullivan |
| ÀεµÀÇ Ã¼¿Ü Áø´Ü ½ÃÀå ±Ô¸ð ¹× ±ÔÁ¦ ȯ°æ, °æÇÕ ±â¾÷ÀÇ ÇÁ·ÎÆÄÀÏ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¾Ï°Ë»ç¿¡¼ÀÇ ºÐÀÚÁø´Ü Molecular Diagnostics in Cancer Testing |
|
Pub Time : 2009/12 Published by : Trimark Publications |
| ºÐÀÚÁø´ÜÀ¸·Î ¾Ë·ÁÁø ü¿Ü Áø´Ü ºÐ¾ß¿¡ ´ëÇØ »ó¼¼È÷ ºÐ¼®ÇÏ°í ¾ÏÀÇ °Ë»ç ¹× Ä¡·á¿¡ ¾²ÀÌ´Â ºÐÀÚÁø´Ü ½ÃÀåÀÇ ±Ô¸ð ¹× ¼ºÀå µ¿Çâ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
Point of Care(POC) Áø´Ü ½ÃÀå : ±â¾÷¤ýÁ¦Ç°¤ýÇâÈÄÀÇ Àü¸Á Point of Care Diagnostics: Players, products & future market prospects |
|
Pub Time : 2009/11 Published by : Espicom Business Intelligence |
| ¼¼°èÀÇ Point of Care(POC) Áø´Ü ½ÃÀå ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ½ÃÀå ±Ô¸ð ½ÇÀû ¹× ¿¹Ãø(¡2014³â), ¼ºÀå °ßÀοäÀΤýÀúÇØ¿äÀÎ, Áö¿ªÀû Àü¸Á, POC Áø´Ü Á¦Ç° ¹× ±â¼úÀÇ ÀÓ»ó ºÐ¾ßº° »ó¼¼ ºÐ¼®, ÁÖ¿ä Á¦Ç°ÀÇ °³¿ä, ÁÖ¿ä ±â¾÷ÀÇ ÁÖ·Â Á¦Ç°, ÁÖ¿ä °è¾à¤ýÁ¦ÈÞ µ¿Çâ, R&D µ¿Çâ, À繫 ½ÇÀû µîÀ» ÀüÇØµå¸³´Ï´Ù. |
|
Æ÷ÀÎÆ® ¿Àºê ÄÉ¾î ½ÃÀå : 2010³â ¹× ±× ÀÌÈÄ Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads |
|
Pub Time : 2009/11 Published by : Kalorama Information |
| Æ÷ÀÎÆ® ¿Àºê Äɾî(POC) Áø´Ü ½ÃÀåÀÇ °³¿ä¿Í ¼öÀÍ ¿¹Ãø, Á¦Ç° °³¿ä, 2013³â±îÁöÀÇ µ¿Çâ, ½ÃÀå¿¡ Âü°¡ÇÏ´Â ±â¾÷ 10»çÀÇ ÇÁ·ÎÆÄÀÏÀ» ÇÔ²² ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ ÀÚµ¿¡¤½Å¼Ó ¹Ì»ý¹° °Ë»ç ½ÃÀå Automated and Rapid Microbiological Tests - A Worldwide Market Review |
|
Pub Time : 2009/11 Published by : BizAcumen, Inc. |
| ¼¼°è ÀÚµ¿¡¤½Å¼Ó ¹Ì»ý¹° °Ë»ç ½ÃÀåÀÇ ÇöȲ°ú Àü¸Á¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, ½ÃÀå ±¸Á¶, °¢Á¾ ½ÃÀå ¿µÇâ¿äÀÎ, ÁÖ¿ä Á¦Ç°ÀÇ °³¿ä(¾ÖÇø®ÄÉÀÌ¼Ç À¯Çüº°), ÁÖ¿ä ±â¾÷ÀÇ ´ëó, ¼¼°è ¹× ÁÖ¿ä ±¹°¡ ½ÃÀåÀÇ ½ÃÀå ±Ô¸ð ½ÇÀû¡¤¿¹Ãø(¡2015³â), ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ À¯¹æ »ý°Ë±â±â ½ÃÀå : 2009³â Global Markets for Breast Biopsy Devices 2009 |
|
Pub Time : 2009/11 Published by : iData Research Inc. |
| ¹Ì±¹, À¯·´ ÁÖ¿ä ±¹°¡, ÀϺ»ÀÇ À¯¹æ »ý°Ë±â±â ½ÃÀå¿¡ ´ëÇØ ºÐ¼®Çϰí, ħ »ý°Ë, Áø°øÈíÀÎ »ý°Ë µî ºÎ¹®º° ½ÃÀå ¿¹Ãø, °æÇÕ µ¿Çâ¿¡ ´ëÇØ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ POCT(Point-of-care Testing) ½ÃÀå Point of Care Diagnostic Testing World Markets |
|
Pub Time : 2009/11 Published by : Trimark Publications |
| POCT(Point-of-care Testing)¶ó°í ºÒ¸®´Â ü¿ÜÁø´Ü ½ÃÀå ºÎ¹®¿¡ ´ëÇØ »ó¼¼È÷ ºÐ¼®Çϰí, º´¿ø ¹× Ŭ¸®´Ð µî¿¡¼ »ç¿ëµÇ°í ÀÖ´Â ÀÓ»ó ÃøÁ¤ ÀåÄ¡, ½Ã¾àÀÇ °³¿ä, ¼¼°è ¹× ¹Ì±¹ ½ÃÀåÀÇ ¸Å»ó µ¿Ç⠵ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°èÀÇ Áø´Ü ½ÃÀå : 2009³â 2009 Worldwide Diagnostics Market Research Bundle |
|
Pub Time : 2009/10 Published by : Kalorama Information |
| ¼¼°èÀÇ Ã¼¿ÜÁø´Ü(IVD) ½ÃÀå¿¡ °üÇÑ Á¶»ç ¸®Æ÷Æ® 4±ÇÀ¸·Î ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. |
|
¼¼°èÀÇ ½ÇÇè½Ç Á¤º¸ °ü¸® ½Ã½ºÅÛ Laboratory Information Management Systems |
|
Pub Time : 2009/10 Published by : Global Industry Analysts, Inc. |
| ¼¼°èÀÇ ½ÇÇè½Ç Á¤º¸ °ü¸® ½Ã½ºÅÛ ½ÃÀåÀ» Á¶»ç´ë»óÀ¸·Î ÇÏ¿©, ½ÃÀåÀÇ °³¿ä, Á¤ÀÇ, ÃÖÁ¾ »ç¿ë ºÎ¹®, ½ÃÀåÀÇ µ¿Çâ°ú ¹®Á¦ µî¿¡ ´ëÇÑ »ó¼¼ÇÑ Á¶»ç¤ýºÐ¼®À» Áö¿ªº°·Î ÀüÇØµå¸³´Ï´Ù. |
|
¾ÏÁø´ÜÀÇ ±â¼ú Çõ½Å : ±â¼ú Áøº¸, ¼ºÀå ±âȸ, ÇâÈÄ ½ÃÀå Àü¸Á Innovations in Oncology Diagnostics: Technological advances, growth opportunities and future market outlook |
|
Pub Time : 2009/10 Published by : Business Insights |
| ¾ÏÁø´Ü ºÐ¾ßÀÇ Ãֽбâ¼ú Çõ½Å µ¿ÇâÀ» Á¤¸®ÇÏ°í ¿µ»ó Áø´Ü ¹× ¼¼Æ÷Áø, ºÐÀÚ Áø´Ü,¾à¹°À¯ÀüüÇп¡ À̸£´Â ´Ù¾çÇÑ ±â¼ú µ¿Çâ ¹× ¾÷°è°¡ Á÷¸éÇÑ °úÁ¦¿¡ ´ëÇÑ ¼³¸íÀ» ÀüÇØµå¸³´Ï´Ù. |
|
¹Ì±¹ À¯ÀüÀÚ Áø´Ü Àåºñ ½ÃÀåÀÇ ºÐ¼® U.S. DNA-Based Diagnostic Test and Equipment Market Analysis & Directions |
|
Pub Time : 2009/09 Published by : Fuji-Keizai U.S.A., Inc. |
| ¹Ì±¹ À¯ÀüÀÚ Áø´Ü ÀåºñÀÇ ½ÃÀå µ¿Çâ, ½ÅÁ¦Ç° °³¹ß µ¿Çâ, ±â¼ú µ¿Çâ, À¯Åë ±¸Á¶ µîÀ» ºÐ¼®Çϰí ÁÖ¿ä ±â¾÷ 15»çÀÇ »ç·Ê ¿¬±¸¸¦ ÀüÇØµå¸³´Ï´Ù. |
|
ÇÁ¶û½ºÀÇ Ç÷¾×ÀºÇà °ü·Ã ½ÃÀå : ¡2013³â The French Blood Banking Market Through 2013 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ÇÁ¶û½ºÀÇ Ç÷¾×ÀºÇà °ü·Ã °Ë»ç¡¤Áø´Ü±â¼ú, ÀáÀçÀû ¾ÖÇø®ÄÉÀ̼ÇÀ» Æ÷°ýÀûÀ¸·Î ºÐ¼®ÇßÀ¸¸ç, ÇÁ¶û½º ½ÃÀåÀÇ ºÐ¼®, Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× Àå¾Ö, °æÇÕ Æò°¡ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
µ¶ÀÏÀÇ Ç÷¾×ÀºÇà °ü·Ã ½ÃÀå : ¡2013³â The German Blood Banking Market Through 2013 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| µ¶ÀÏÀÇ Ç÷¾×ÀºÇà °ü·Ã °Ë»ç¡¤Áø´Ü±â¼ú, ÀáÀçÀû ¾ÖÇø®ÄÉÀ̼ÇÀ» Æ÷°ýÀûÀ¸·Î ºÐ¼®ÇßÀ¸¸ç, µ¶ÀÏ ½ÃÀåÀÇ ºÐ¼®, Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× Àå¾Ö, °æÇÕ±â¾÷ Æò°¡ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
ÀÌÅ»¸®¾ÆÀÇ Ç÷¾×ÀºÇà °ü·Ã ½ÃÀå : ¡2013³â The Italian Blood Banking Market Through 2013 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ÀÌÅ»¸®¾ÆÀÇ Ç÷¾×ÀºÇà °ü·Ã °Ë»ç¡¤Áø´Ü±â¼ú, ÀáÀçÀû ¾ÖÇø®ÄÉÀ̼ÇÀ» Æ÷°ýÀûÀ¸·Î ºÐ¼®ÇßÀ¸¸ç, ÀÌÅ»¸®¾Æ ½ÃÀåÀÇ ºÐ¼®, Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× Àå¾Ö, °æÇÕ±â¾÷ Æò°¡ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
ÀϺ»ÀÇ Ç÷¾×ÀºÇà °ü·Ã ½ÃÀå : ¡2013³â The Japanese Blood Banking Market Through 2013 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ÀϺ»ÀÇ Ç÷¾×ÀºÇà °ü·Ã °Ë»ç¡¤Áø´Ü±â¼ú, ÀáÀçÀû ¾ÖÇø®ÄÉÀ̼ÇÀ» Æ÷°ýÀûÀ¸·Î ºÐ¼®ÇßÀ¸¸ç, ÀϺ» ½ÃÀåÀÇ ºÐ¼®, Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× Àå¾Ö, °æÇÕ±â¾÷ Æò°¡ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
½ºÆäÀÎÀÇ Ç÷¾×ÀºÇà °ü·Ã ½ÃÀå : ¡2013³â The Spanish Blood Banking Market Through 2013 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ½ºÆäÀÎÀÇ Ç÷¾×ÀºÇà °ü·Ã °Ë»ç¡¤Áø´Ü±â¼ú, ÀáÀçÀû ¾ÖÇø®ÄÉÀ̼ÇÀ» Æ÷°ýÀûÀ¸·Î ºÐ¼®ÇßÀ¸¸ç, ½ºÆäÀÎ ½ÃÀåÀÇ ºÐ¼®, Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× Àå¾Ö, °æÇÕ±â¾÷ Æò°¡ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¿µ±¹ÀÇ Ç÷¾×ÀºÇà °ü·Ã ½ÃÀå : ¡2013³â The UK Blood Banking Market Through 2013 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ¿µ±¹ÀÇ Ç÷¾×ÀºÇà °ü·Ã °Ë»ç¡¤Áø´Ü±â¼ú, ÀáÀçÀû ¾ÖÇø®ÄÉÀ̼ÇÀ» Æ÷°ýÀûÀ¸·Î ºÐ¼®ÇßÀ¸¸ç, ¿µ±¹ ½ÃÀåÀÇ ºÐ¼®, Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× Àå¾Ö, °æÇÕ±â¾÷ Æò°¡ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¹Ì±¹ÀÇ Ç÷¾×ÀºÇà °ü·Ã ½ÃÀå : ¡2013³â The US Blood Banking Market Through 2013 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ¹Ì±¹ÀÇ Ç÷¾×ÀºÇà °ü·Ã °Ë»ç¡¤Áø´Ü±â¼ú, ÀáÀçÀû ¾ÖÇø®ÄÉÀ̼ÇÀ» Æ÷°ýÀûÀ¸·Î ºÐ¼®ÇßÀ¸¸ç, ¹Ì±¹ ½ÃÀåÀÇ ºÐ¼®, Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× Àå¾Ö, °æÇÕ±â¾÷ Æò°¡ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
ÇÁ¶û½ºÀÇ ¾ÏÁø´Ü ½ÃÀå The French Cancer Diagnostics Market |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ¾ÏÀÇ Áø´Ü±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, °¢Á¾ Áø´Ü°Ë»çÀÇ Á¾·ù ¹× ¹æ¹ý, ±â¼ú ¸®ºä¿Í ÇÔ²² ÇÁ¶û½º ½ÃÀåÀÇ ºÐ¼®, ÁÖ¿ä Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× À庮, ÁÖ¿ä °ø±Þ¾÷ü ÇÁ·ÎÆÄÀÏÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
µ¶ÀÏÀÇ ¾ÏÁø´Ü ½ÃÀå The German Cancer Diagnostics Market |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ¾ÏÀÇ Áø´Ü±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, °¢Á¾ Áø´Ü°Ë»çÀÇ Á¾·ù ¹× ¹æ¹ý, ±â¼ú ¸®ºä¿Í ÇÔ²² µ¶ÀÏ ½ÃÀåÀÇ ºÐ¼®, ÁÖ¿ä Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× À庮, ÁÖ¿ä °ø±Þ¾÷ü ÇÁ·ÎÆÄÀÏÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
ÀÌÅ»¸®¾ÆÀÇ ¾ÏÁø´Ü ½ÃÀå The Italian Cancer Diagnostics Market |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ¾ÏÀÇ Áø´Ü±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, °¢Á¾ Áø´Ü°Ë»çÀÇ Á¾·ù ¹× ¹æ¹ý, ±â¼ú ¸®ºä¿Í ÇÔ²² ÀÌÅ»¸®¾Æ ½ÃÀåÀÇ ºÐ¼®, ÁÖ¿ä Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× À庮, ÁÖ¿ä °ø±Þ¾÷ü ÇÁ·ÎÆÄÀÏÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
ÀϺ»ÀÇ ¾ÏÁø´Ü ½ÃÀå The Japanese Cancer Diagnostics Market |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ¾ÏÀÇ Áø´Ü±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, °¢Á¾ Áø´Ü°Ë»çÀÇ Á¾·ù ¹× ¹æ¹ý, ±â¼ú ¸®ºä¿Í ÇÔ²² ÀϺ» ½ÃÀåÀÇ ºÐ¼®, ÁÖ¿ä Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× À庮, ÁÖ¿ä °ø±Þ¾÷ü ÇÁ·ÎÆÄÀÏÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
½ºÆäÀÎÀÇ ¾ÏÁø´Ü ½ÃÀå The Spanish Cancer Diagnostics Market |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ¾ÏÀÇ Áø´Ü±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, °¢Á¾ Áø´Ü°Ë»çÀÇ Á¾·ù ¹× ¹æ¹ý, ±â¼ú ¸®ºä¿Í ÇÔ²² ½ºÆäÀÎ ½ÃÀåÀÇ ºÐ¼®, ÁÖ¿ä Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× À庮, ÁÖ¿ä °ø±Þ¾÷ü ÇÁ·ÎÆÄÀÏÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¿µ±¹ÀÇ ¾ÏÁø´Ü ½ÃÀå The UK Cancer Diagnostics Market |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ¾ÏÀÇ Áø´Ü±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, °¢Á¾ Áø´Ü°Ë»çÀÇ Á¾·ù ¹× ¹æ¹ý, ±â¼ú ¸®ºä¿Í ÇÔ²² ¿µ±¹ ½ÃÀåÀÇ ºÐ¼®, ÁÖ¿ä Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× À庮, ÁÖ¿ä °ø±Þ¾÷ü ÇÁ·ÎÆÄÀÏÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¹Ì±¹ÀÇ ¾ÏÁø´Ü ½ÃÀå The US Cancer Diagnostics Market |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ¾ÏÀÇ Áø´Ü±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, °¢Á¾ Áø´Ü°Ë»çÀÇ Á¾·ù ¹× ¹æ¹ý, ±â¼ú ¸®ºä¿Í ÇÔ²² ¹Ì±¹ ½ÃÀåÀÇ ºÐ¼®, ÁÖ¿ä Á¦Ç° °³¹ßÀÇ ±âȸ, ½ÃÀå Âü°¡ÀÇ Àü·« ¹× À庮, ÁÖ¿ä °ø±Þ¾÷ü ÇÁ·ÎÆÄÀÏÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¾Ï Áø´Ü ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ : ÁÖ¿ä °ø±Þ¾÷ü/½ÅÈï ½ÃÀå Âü°¡ ±â¾÷¿¡ ´ëÇÑ Àü·«Àû Æò°¡ Leading Cancer Diagnostics Market Players: Strategic Assessments of Major Suppliers and Emerging Market Entrants |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ¼¼°è ¾Ï Áø´Ü ½ÃÀå ÁÖ¿ä ±â¾÷ 62»çÀÇ ¸ÅÃâ, ½ÃÀå Á¡À¯À², Á¦Ç° Æ÷Æ®Æú¸®¿À, À¯Åë Àü·«, ±â¼ú Á¤º¸, ¿¬±¸°³¹ßÁßÀÎ ½ÅÁ¦Ç°, Á¦ÈÞ, ºñÁî´Ï½º Àü·« µî¿¡ ´ëÇØ Àü·«Àû Æò°¡¸¦ Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¾Ï Áø´Ü ±â¼ú : ÇöÀç ±â¼ú ¹× ½Å±â¼ú°ú ½ÃÀå¿¡¼ÀÇ ÀÀ¿ë ºÐ¼® Cancer Diagnostic Technologies: Assessment of Current and Emerging Technologies, and Their Potential Market Applications |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| ´Ù¾çÇÑ ¾Ï Áø´Ü ±â¼ú¿¡ ´ëÇØ ºÐ¼®ÇÏ°í ½ÃÀå¿¡¼ÀÇ ÀÀ¿ë µ¿Çâ¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°è ¹× ÇÁ¶û½ºÀÇ Ç÷¾×ÀÀ°í °Ë»ç ½ÃÀå : 2009³â¡2018³â The French Coagulation Market, 2009-2018 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| Ç÷¾×ÀÀ°í °Ë»ç ±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, °¢Á¾ °Ë»çÀÇ Á¾·ù¿Í ¹æ¹ý, ±â¼ú ¸®ºä, ÁÖ¿ä Á¦Ç°¡¤±â¼úÀÇ ½ÃÀå ±Ô¸ð ½ÇÀû¡¤¿¹Ãø(¼¼°è ¹× ÇÁ¶û½º), °Ë»ç °Ç¼ö ½ÇÀû¡¤¿¹Ãø(¼¼°è ¹× ÇÁ¶û½º), ÁÖ¿ä °ø±ÞÀÚÀÇ ½ÃÀå Á¡À¯À², ½ÃÀå ħÅõ Àü·«, °úÁ¦, Á¦¾ð µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°è ¹× µ¶ÀÏÀÇ Ç÷¾×ÀÀ°í °Ë»ç ½ÃÀå : 2009³â¡2018³â The German Coagulation Market, 2009-2018 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| Ç÷¾×ÀÀ°í °Ë»ç ±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, °¢Á¾ °Ë»çÀÇ Á¾·ù¿Í ¹æ¹ý, ±â¼ú ¸®ºä, ÁÖ¿ä Á¦Ç°¡¤±â¼úÀÇ ½ÃÀå ±Ô¸ð ½ÇÀû¡¤¿¹Ãø(¼¼°è ¹× µ¶ÀÏ), °Ë»ç °Ç¼ö ½ÇÀû¡¤¿¹Ãø(¼¼°è ¹× µ¶ÀÏ), ÁÖ¿ä °ø±ÞÀÚÀÇ ½ÃÀå Á¡À¯À², ½ÃÀå ħÅõ Àü·«, °úÁ¦, Á¦¾ð µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°è ¹× ÀÌÅ»¸®¾ÆÀÇ Ç÷¾×ÀÀ°í °Ë»ç ½ÃÀå : 2009³â¡2018³â The Italian Coagulation Market, 2009-2018 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| Ç÷¾×ÀÀ°í °Ë»ç ±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, °¢Á¾ °Ë»çÀÇ Á¾·ù¿Í ¹æ¹ý, ±â¼ú ¸®ºä, ÁÖ¿ä Á¦Ç°¡¤±â¼úÀÇ ½ÃÀå ±Ô¸ð ½ÇÀû¡¤¿¹Ãø(¼¼°è ¹× ÀÌÅ»¸®¾Æ), °Ë»ç °Ç¼ö ½ÇÀû¡¤¿¹Ãø(¼¼°è ¹× ÀÌÅ»¸®¾Æ), ÁÖ¿ä °ø±ÞÀÚÀÇ ½ÃÀå Á¡À¯À², ½ÃÀå ħÅõ Àü·«, °úÁ¦, Á¦¾ð µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°è ¹× ÀϺ»ÀÇ Ç÷¾×ÀÀ°í °Ë»ç ½ÃÀå : 2009³â¡2018³â The Japanese Coagulation Market, 2009-2018 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| Ç÷¾×ÀÀ°í °Ë»ç ±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®Çϰí, °¢Á¾ °Ë»çÀÇ Á¾·ù¿Í ¹æ¹ý, ±â¼ú ¸®ºä, ÁÖ¿ä Á¦Ç°¡¤±â¼úÀÇ ½ÃÀå ±Ô¸ð ½ÇÀû¡¤¿¹Ãø(¼¼°è ¹× ÀϺ»), °Ë»ç °Ç¼ö ½ÇÀû¡¤¿¹Ãø(¼¼°è ¹× ÀϺ»), ÁÖ¿ä °ø±ÞÀÚÀÇ ½ÃÀå Á¡À¯À², ½ÃÀå ħÅõ Àü·«, °úÁ¦, Á¦¾ð µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°è¤ý½ºÆäÀÎÀÇ Ç÷¾× ÀÀ°í °Ë»ç ½ÃÀå : 2009¡2018³â The Spanish Coagulation Market, 2009-2018 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| Ç÷¾× ÀÀ°í °Ë»çÀÇ ±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ°í °¢Á¾ °Ë»çÀÇ Á¾·ù¿Í ¹æ¹ý, ±â¼ú ¸®ºä, ÁÖ¿ä Á¦Ç°¤ý±â¼úÀÇ ½ÃÀå ±Ô¸ð ½ÇÀû°ú ¿¹Ãø(¼¼°è¤ý½ºÆäÀÎ), °Ë»ç °Ç¼öÀÇ ½ÇÀû¤ý¿¹Ãø(¼¼°è¤ý½ºÆäÀÎ), ÁÖ¿ä °ø±Þ¾÷üÀÇ ½ÃÀå Á¡À¯À², ½ÃÀå Âü°¡ Àü·«, °úÁ¦ ¹× Á¦¾ð µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°è¤ý¿µ±¹ÀÇ Ç÷¾× ÀÀ°í °Ë»ç ½ÃÀå : 2009¡2018³â The UK Coagulation Market, 2009-2018 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| Ç÷¾× ÀÀ°í °Ë»çÀÇ ±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ°í °¢Á¾ °Ë»çÀÇ Á¾·ù¿Í ¹æ¹ý, ±â¼ú ¸®ºä, ÁÖ¿ä Á¦Ç°¤ý±â¼úÀÇ ½ÃÀå ±Ô¸ð ½ÇÀû°ú ¿¹Ãø(¼¼°è¤ý¿µ±¹), °Ë»ç °Ç¼öÀÇ ½ÇÀû¤ý¿¹Ãø(¼¼°è¤ý¿µ±¹), ÁÖ¿ä °ø±Þ¾÷üÀÇ ½ÃÀå Á¡À¯À², ½ÃÀå Âü°¡ Àü·«, °úÁ¦ ¹× Á¦¾ð µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
¼¼°è¤ý¹Ì±¹ÀÇ Ç÷¾× ÀÀ°í °Ë»ç ½ÃÀå : 2009¡2018³â The US Coagulation Market, 2009-2018 |
|
Pub Time : 2009/09 Published by : Venture Planning Group |
| Ç÷¾× ÀÀ°í °Ë»çÀÇ ±â¼ú ¹× Á¦Ç° ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ°í °¢Á¾ °Ë»çÀÇ Á¾·ù¿Í ¹æ¹ý, ±â¼ú ¸®ºä, ÁÖ¿ä Á¦Ç°¤ý±â¼úÀÇ ½ÃÀå ±Ô¸ð ½ÇÀû°ú ¿¹Ãø(¼¼°è¤ý¹Ì±¹), °Ë»ç °Ç¼öÀÇ ½ÇÀû¤ý¿¹Ãø(¼¼°è¤ý¹Ì±¹), ÁÖ¿ä °ø±Þ¾÷üÀÇ ½ÃÀå Á¡À¯À², ½ÃÀå Âü°¡ Àü·«, °úÁ¦ ¹× Á¦¾ð µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
ÀεµÀÇ ÀÓ»óÁø´Ü ¾÷°è Who is Who in Clinical Diagnostics in India (Markets, Distributors, Companies, Countr Overview) |
|
Pub Time : 2009/08 Published by : Kalorama Information |
| Àεµ Áø´Ü ¾÷°èÀÇ °³¿ä ¹× º´¿ø Åë°è, 42°³ ±¹Á¦ ±â¾÷, 130°³ Àεµ ±â¾÷, 24°³ ÆÇ¸Å¾÷ÀÚÀÇ ÇÁ·ÎÆÄÀÏÀ» ÀüÇØµå¸³´Ï´Ù. |
|
°¨¿°Áõ Áø´Ü ½ÃÀå Infectious Disease Diagnostic Markets |
|
Pub Time : 2009/08 Published by : Kalorama Information |
| ¼¼±Õ¤ý¹ÙÀÌ·¯½º °¨¿°ÀÇ Áø´Ü¿¡ ¾²¿©Áö´Â Á¦Ç°¿¡ ÃÊÁ¡À» ¸ÂÃß°í ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¿¹Ãø, °¨¿°Áõ Áø´Ü ½ÃÀåÀÇ ÇâÈÄ 10³â°£ÀÇ Àå±âÀû ¿¹Ãø, ÁÖ¿ä Á¦Ç° °³¿ä, ½ÃÀåÀÇ °æÇÕ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
EMMA09 : »ý¸í °úÇФýü¿Ü Áø´Ü ºÐ¾ßÀÇ »õ·Î¿î ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ½ÃÀå EMMA09 - Emerging Markets for Microfluidic Appliations in Life Sciences and In-Vitro Diagnostics |
|
Pub Time : 2009/08 Published by : Yole Developpement |
| »ý¸í °úÇФýü¿Ü Áø´Ü ºÐ¾ßÀÇ ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½ºÀÇ »õ·Î¿î ¾ÖÇø®ÄÉÀ̼ǰú ±× ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇÏ°í ½ÃÀå ¿¹Ãø(¡2014³â), 2007³âºÎÅÍÀÇ ½ÃÀå ÃßÀÌ¿Í º¯È, ÁÖ¿ä ¾ÖÇø®ÄÉÀ̼Ǻ° ½ÃÀå µ¿Çâ, °¢Á¾ ±â¼úÀÇ °³¿ä ¹× ÁøÈ, °ø±Þ¸Á ºÐ¼®, °¡Ä¡ »ç½½ÀÇ »ç·Ê ¿¬±¸ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
Ç÷¾× ºÐ¼® Àåºñ ¹× ½Ã¾à ½ÃÀå Hematology Analyzer Instrumentation and Reagent Markets |
|
Pub Time : 2009/07 Published by : Trimark Publications |
| ¼¼°èÀÇ Ç÷¾× ºÐ¼® Àåºñ ¹× ½Ã¾à ½ÃÀåÀ» ¼¼ºÐº°·Î ºÐ·ùÇϰí, °¢ ºÐ¾ßÀÇ ±â¼ú°³¹ß µ¿Çâ°ú ½ÃÀå±âȸ, ½ÃÀå¿¡ Âü°¡ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÇ ÇÁ·ÎÆÄÀÏ µîÀ» ÇÔ²² ÀüÇØµå¸³´Ï´Ù. |
|
ü¿ÜÁø´Ü(IVD) ºÐ¾ß¿¡¼ ½ÅÁ¦Ç° ¹× ½Å±â¼úÀÇ »óÇ°È What is Working in IVD: Successful Commercialization of New Products and Technologies |
|
Pub Time : 2009/07 Published by : Kalorama Information |
| ü¿ÜÁø´Ü ½ÃÀåÀÇ Àü·«Àû ½ÃÀå °èȹ, ÁöÀûÀç»ê°ú ƯÇ㺸ȣ, ±ÔÁ¦ ÇÁ·Î¼¼½º °ü¸®, º¸»ó, Á¦Ç°ÀÇ ¶óÀÌÇÁ»çÀÌŬ µî¿¡ ´ëÇÑ ºÐ¼®À» ÀüÇØµå¸³´Ï´Ù. |
|
À¯ÀüÀÚ °Ë»çÀÇ °ú¿ µ¿Çâ Key Trends Fueling the Boom in Genetic Testing |
|
Pub Time : 2009/06 Published by : Decision Resources, Inc. |
| ¹ÙÀÌ¿ÀÆÄ¸¶ÀÇ ±â¼ú Çõ½Å µ¿Çâ, ½ÃÀå Âü°¡ ±â¾÷ÀÇ Àü·«, Â÷¼¼´ë ½ÃÄö½Ì ¹× »óȯ, ºê·£µù µî ÇâÈÄÀÇ À¯ÀüÀÚ °Ë»ç ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¿äÀÎ µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù. |
|
ÀÓ»ó°Ë»ç ½ÃÀå¿¡ °üÇÑ º¸°í¼ ¼¼Æ® Clinical Bundle |
|
Pub Time : 2009/06 Published by : Trimark Publications |
| Trimark Publications°¡ ¹ßÇàÇÑ ÀÓ»ó°Ë»ç »çÀå °ü·Ã º¸°í¼ 4±ÇÀ» ¸ð¾Æ¼ Á¦°øÇØ µå¸³´Ï´Ù. |
|
POCT(Point-of-care Testing) µ¿Çâ Point of Care Diagnostic Testing Sector Trends |
|
Pub Time : 2009/06 Published by : Trimark Publications |
| POCT(Point-of-care Testing) ½ÃÀåÀÇ ÇöȲ ¹× ¿¹Ãø, ¼ºÀå·ü, ÁÖ¿äÁ¦Ç° ¹× ¿¬±¸°³¹ß °ü·Ã ÃֽŠÁ¤º¸, ½ÃÀåÀÇ ±âȸ ¹× °úÁ¦ µî¿¡ ´ëÇØ ÀüÇØµå¸³´Ï´Ù. |
|
ü¿ÜÁø´ÜÀÇ ±â¼ú Çõ½Å : ½Å±â¼ú, ¼ºÀå±âȸ ¹× ÇâÈÄÀÇ ½ÃÀå Àü¸Á Innovations in In-Vitro Diagnostics: New technologies, growth opportunities, and the future market outlook |
|
Pub Time : 2009/06 Published by : Business Insights |
| Áø´Ü¹ý °³¹ßÀÇ ¹æÇ⼺À» Á¿ìÇÏ´Â ÁÖ¿ä µ¿Çâ ¹× ¹®Á¦Á¡À» ºÐ¼®Çϰí, ½Å±â¼úÀÇ Àå·¡¼ºÀ» Æò°¡ÇÏ¿© ±×·ÎºÎÅÍ ¾òÀ» ¼ö ÀÖ´Â Á¤º¸¿Í °æÇÕ È¯°æÀÇ Æò°¡ µîµµ ÇÔ²² ÀüÇØµå¸³´Ï´Ù. |
|
|
|